Free Trial
OTCMKTS:CNBX

CNBX Pharmaceuticals (CNBX) Stock Price, News & Analysis

CNBX Pharmaceuticals logo
$0.0006 0.00 (0.00%)
As of 07/11/2025 03:59 PM Eastern

About CNBX Pharmaceuticals Stock (OTCMKTS:CNBX)

Key Stats

Today's Range
$0.0005
$0.0007
50-Day Range
N/A
52-Week Range
$0.0005
$0.0199
Volume
9.46 million shs
Average Volume
4.67 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CNBX Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

CNBX MarketRank™: 

CNBX Pharmaceuticals scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CNBX Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CNBX Pharmaceuticals is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CNBX Pharmaceuticals is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    CNBX Pharmaceuticals has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    CNBX Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    CNBX Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    CNBX Pharmaceuticals has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Search Interest

    4 people have searched for CNBX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CNBX Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    73.51% of the stock of CNBX Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    98.18% of the stock of CNBX Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CNBX Pharmaceuticals' insider trading history.
Receive CNBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CNBX Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CNBX Stock News Headlines

Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
CNBX Pharmaceuticals Inc CNBX
CNBX Historical Data
CNBX - CNBX Pharmaceuticals Inc.
See More Headlines

CNBX Stock Analysis - Frequently Asked Questions

CNBX Pharmaceuticals' stock was trading at $0.0074 at the beginning of the year. Since then, CNBX shares have decreased by 91.9% and is now trading at $0.0006.

Shares of CNBX Pharmaceuticals reverse split on the morning of Thursday, May 12th 2022.The 1-120 reverse split was announced on Thursday, May 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of CNBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CNBX Pharmaceuticals investors own include Organigram Global (OGI), Green Thumb Industries (GTBIF), Canopy Growth (CGC), Curaleaf (CURLF), Cannabis Science (CBIS), Kushco (KSHB) and Trulieve Cannabis (TCNNF).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:CNBX
CIK
1343009
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:CNBX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners